$391 Million is the total value of Wildcat Capital Management, LLC's 25 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 44.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CSGP | Sell | COSTAR GROUP INC | $30,353,000 | -27.3% | 455,685 | -13.8% | 7.77% | +14.2% |
BKNG | Sell | BOOKING HOLDINGS INC | $19,753,000 | -42.9% | 8,411 | -41.6% | 5.05% | -10.2% |
LBRDK | Sell | LIBERTY BROADBAND CORP | $19,522,000 | -38.7% | 144,265 | -27.0% | 5.00% | -3.6% |
CPNG | Sell | COUPANG INCcl a | $15,202,000 | -56.9% | 859,817 | -28.4% | 3.89% | -32.3% |
SNOW | Sell | SNOWFLAKE INCcl a | $362,000 | -85.0% | 1,578 | -77.9% | 0.09% | -76.4% |
INTU | Exit | INTUIT | $0 | – | -769 | -100.0% | -0.08% | – |
FIGS | Exit | FIGS INCcl a | $0 | – | -21,207 | -100.0% | -0.10% | – |
SPCE | Exit | VIRGIN GALACTIC HOLDINGS INC | $0 | – | -75,645 | -100.0% | -0.16% | – |
PCOR | Exit | PROCORE TECHNOLOGIES INC | $0 | – | -22,869 | -100.0% | -0.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.